Claritev CTEV 深 沪
已收盘 04-02 16:00:00 美东时间
17.46
+0.630
+3.74%
华盛通- 最 高17.60
- 今 开16.53
- 成交量 8.49万股
- 最 低 16.53
- 昨 收 16.83
- 总市值 2.96亿
- 52周最高 74.0699
- 市盈率 静 --
- 换手率 0.50%
- 52周最低 12.04
- 委 比 0.00%
- 总股本 1696.69万
- 历史最高 74.0699
- 量 比 0.95
- 振 幅 6.36%
- 历史最低 0.173
- 每 手 1
- 风险率 16.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Claritev Corporation Announces Annual Stockholders Meeting
Claritev Corporation Announces Annual Stockholders Meeting Claritev will hold its annual meeting online on April 29, 2026. Shareholders will vote on the election of four Class III director nominees: Anthony Colaluca Jr., Michael Klein, Allen Thorpe and Dale White. The meeting agenda also includes ra
03-20 18:45
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
Wells Fargo Maintains Equal-Weight on Claritev, Lowers Price Target to $22
Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lowers the price target from $30 to $22.
03-19 21:46
Claritev EVP and Chief Digital Officer Michael Kim acquires USD 248,000 in common shares
Claritev EVP and Chief Digital Officer Michael Kim acquires USD 248,000 in common shares Michael Kim, EVP and Chief Digital Officer, acquired 15,000 shares of Claritev Class A common stock. The shares were purchased at USD 16.5 per share. Following the acquisition, Kim reported beneficial ownership
03-16 20:42
Alpha Buying: Following the Insiders Into a Volatile Market
We knew the risks were there. For months I have said the two biggest threats to...
03-06 00:18
Claritev Corporation to Join Mizuho Virtual Healthcare Technology Conference 2026
Claritev Corporation to Join Mizuho Virtual Healthcare Technology Conference 2026 Claritev Corporation (NYSE: CTEV) said its management team will meet with investors at the Mizuho Virtual Healthcare Technology Conference 2026 on March 5, 2026, and will also participate in a Q&A webcast hosted by Nep
03-04 21:00
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, FactSet, IBM
BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, FactSet, IBM Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks rebounded on Tuesday, led by recovering technology shares as inv
02-25 03:00
Wells Fargo Maintains Equal-Weight on Claritev, Lowers Price Target to $30
Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lowers the price target from $33 to $30.
02-24 22:45
